Olivetree posts FY 2025 net loss of SGD 1.47 million (+182%)

Reuters
02/23
Olivetree posts FY 2025 net loss of SGD 1.47 million (+182%)

Olive Tree Estates (OTE) reported FY2025 revenue of SGD 1.28 million (+1%) and a net loss of SGD 1.47 million (+182%), according to its full-year results for the year ended 31 December 2025. For 2H2025, revenue was SGD 0.63 million (-1%) and net loss was SGD 0.36 million (-35%). FY2025 administrative expenses were SGD 1.92 million (-11%), finance expenses were SGD 0.17 million (-38%), and other gains/(losses) were a loss of SGD 0.66 million (from a gain in FY2024). Basic and diluted loss per share for FY2025 was 1.27 cents. As at 31 December 2025, OTE had cash and bank balances of SGD 7.19 million (up from SGD 1.94 million), total assets of SGD 14.59 million, total liabilities of SGD 6.15 million, and net asset value per share of 7.28 cents. The company said cash rose mainly due to proceeds from the sale of non-current assets previously classified as held for sale, and noted its Singapore investment property portfolio remained fully occupied, providing recurring rental income. It also highlighted the completion of a mandatory general offer in December 2025 and the appointment of three new independent directors in February 2026, with the group evaluating business options to increase shareholder value.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Olive Tree Estates Limited published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: R9QVMSDGMPAOWZOF) on February 23, 2026, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10